NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Paladin Labs Inc. 

6111 Royalmount Avenue, Suite 102

Montreal  Quebec  H4P 2T4  Canada
Phone: 514-340-1112 Fax: 514-344-4675


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
Paladin Labs Inc. (CC:PLB) Reports Record Third Quarter 2009 Financial Results 11/11/2009 11:06:54 AM    More...
Paladin Labs Inc. (CC:PLB) Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research From Bill & Melinda Gates Foundation 10/23/2009 9:48:09 AM    More...
Paladin Labs Inc. (CC:PLB) and Pfizer Inc. (PFE) (JOBS) Amend Canadian Estring(R) Agreement 10/15/2009 6:27:22 AM    More...
Paladin Labs Inc. (CC:PLB) to Present at BioContact Conference in Quebec City 10/1/2009 11:35:27 AM    More...
Paladin Labs Inc. (CC:PLB) Announces Sale of Antibody Platform to Quest PharmaTech Inc. 9/30/2009 10:58:20 AM    More...
Health Canada Approves Paladin Labs Inc. (CC:PLB)'s GlucaGen(R) for Treatment of Severe Hypoglycemia in Diabetes Patients 9/24/2009 10:55:12 AM    More...
Paladin Labs Inc. (CC:PLB) to Present at the UBS Global Life Sciences Conference in New York City 9/18/2009 10:37:20 AM    More...
Paladin Labs Inc. (CC:PLB) Announces Sale of T-ACT Platform to IMBiotechnologies 8/14/2009 10:31:53 AM    More...
Paladin Labs Inc. (CC:PLB) Reports 2009 Second Quarter Financial Results 8/11/2009 9:51:11 AM    More...
Paladin Labs Inc. (CC:PLB) Reports 2009 Second Quarter Financial Results 8/11/2009 9:43:46 AM    More...
12345678910...